Effect of treatment for 3 months with human parathyroid hormone 1–34 peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis).
- 31 October 1995
- Vol. 17 (4), S415-S420
- https://doi.org/10.1016/8756-3282(95)00320-d
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Parathyroid Hormone for the Prevention of Bone Loss Induced by Estrogen DeficiencyNew England Journal of Medicine, 1994
- Anabolic effect of high doses of human parathyroid hormone (1–38) in mature intact female ratsJournal of Bone and Mineral Research, 1994
- Estimated intracortical bone turnover in the femur of growing macaques: Implications for their use as models in skeletal pathologyThe Anatomical Record, 1992
- Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1–38) and salmon calcitonin in osteoporotic patientsBone and Mineral, 1991
- Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride.BMJ, 1990
- Resorption is not essential for the stimulation of bone growth by hPTH-(1-34) in rats in vivoJournal of Bone and Mineral Research, 1989
- Human Parathyroid Hormone-(l–34) Increases Bone Mass in Ovariectomized and Orchidectomized Rats*Endocrinology, 1988
- Histomorphometric evaluation on ilium of beagle dogs with long term administration of low dose 1–34 H PTHBone, 1985
- The relationship between changes in femoral bone density and calcium balance in patients with involutional osteoporosis treated with human parathyroid hormone fragment (hPTH 1–34)Metabolic Bone Disease and Related Research, 1981
- Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.BMJ, 1980